Status:
UNKNOWN
Exploration of the Mechanisms of Vulnerability of Anorexia Nervosa at an Early Age : Study of the Cognitive Treatment of Food Stimuli and Body Image
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Anorexia Nervosa
Eligibility:
All Genders
8-14 years
Phase:
NA
Brief Summary
In order to explore the cognitive treatment of patients with early onset anorexia nervosa (AM) in front of images of silhouettes and food, we will use the eye-tracking method. While we hypothesize a j...
Detailed Description
Monocentric, prospective cohort, case-control type study. The population concerned is composed of patients with early onset anorexia nervosa (AM) and control subjects (two groups). The objectives of ...
Eligibility Criteria
Inclusion
- Patients with anorexia nervosa.
- Age 8 to 14 years,
- Early AM diagnosis (AM DSM-5 criteria, and presence of primary amenorrhea at diagnosis for girls),
- Follow-up in the Child Psychiatry Department of the Robert Debré Hospital,
- Affiliation to a social security system,
- Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research.
- Witnesses from the general population:
- Age 8 to 14 years,
- Normal Height-weight development defined by: Weight, Height, BMI between 10° and 90° percentile for age and sex, without changing the growth curve.
- Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research
- Witnesses with type 1 diabetes:
- Age 8 to 14 years,
- Type 1 diabetes for more than a year,
- Follow-up in the endocrinology department of the Robert Debré Hospital,
- Normal height-weight development defined by: Weight, Height, BMI between 10° and 90° percentile for age and sex, without changing the growth curve.
- No clear imbalance with HbA1c \<8.5%.
- Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research
Exclusion
- Patients with AM.
- Existence of an intellectual deficit (IQ \<70). The patient will not be able to have a new IQ test within one year of inclusion.
- Other Axis I disorder (Kiddie SAS)
- Existence of a severe neurosensory disorder
- Existence of a neurological disorder
- other eating disorders(DSM-5)
- Diabetes type 1
- Witnesses :
- Any Axis I psychiatric disorder
- Existence of an intellectual deficit
- Existence of a severe neurosensory disorder
- Existence of a neurological disorder
- Long-term drug treatment (other than insulin for controls with type 1 diabetes)
- Type 1 diabetes (for controls in the general population)
- Psychometric test taken in the year before inclusion
Key Trial Info
Start Date :
November 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 19 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04037215
Start Date
November 19 2019
End Date
December 19 2022
Last Update
October 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Robert Debré
Paris, France, 75019